Lexeo Therapeutics, Inc. (LXEO) stock
LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$2.95+0.10 (+3.33%)
Close on Nov 18, 2026Market cap $242.04MP/E –Yield –
Lexeo Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Lexeo Therapeutics's profit margin for the twelve months ending Dec 31, 2022 was -9063.8%. For fiscal 2022 it was -9063.8%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -9063.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2022 | Sep 30, 2022 | -3211.9% | – |
See a number that looks wrong?